FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Eurofins Scientific SE Stock AnalysisComprehensive stock analysis for Eurofins Scientific SE (ERFSF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisERFSF
ERFSF
Eurofins Scientific SE
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ERFSF
Home🔹Stocks🔹Eurofins Scientific SE

Eurofins Scientific SE

🇺🇸ERFSF•OTC

Eurofins Scientific SE

🇺🇸ERFSF•OTC
Market cap
$14.44B
Sentiment

Your view on ERFSF

Mkt Cap
$14.44B
Sentiment
Your view
ERFSF
Eurofins Scientific SE
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ERFSF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Eurofins Scientific SE

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Gilles G. Martin
Headquarters
23 Val Fleuri, Luxembourg City, LU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Gilles G. Martin
Headquarters
23 Val Fleuri, Luxembourg City, LU
Description

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics.

In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing.

Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services.

Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Eurofins Scientific SE, and the rating behind it. ERFSF last traded at $80.83, 23.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Eurofins Scientific SE. Starting points for Eurofins Scientific SE: P/E 23.6, EPS $3.02, beta 0.96 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Eurofins Scientific SE. Eurofins Scientific SE does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Eurofins Scientific SE. Trailing twelve-month EPS for Eurofins Scientific SE stands at $3.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Eurofins Scientific SE. Eurofins Scientific SE has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Eurofins Scientific SE valued side by side against its closest peers. Eurofins Scientific SE is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Eurofins Scientific SE, and how their positions are changing. At a $14.44B market value, institutional positions materially move Eurofins Scientific SE's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Eurofins Scientific SE executives and directors. Shares of Eurofins Scientific SE have traded between $48.55 and $86.20 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Eurofins Scientific SE. Eurofins Scientific SE is a $14.44B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Eurofins Scientific SE. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Eurofins Scientific SE. Coverage tracks Eurofins Scientific SE within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BDUUY — Bangkok Dusit Medical Services Public Company Limited
  • BIOVF — Swedish Orphan Biovitrum AB (publ)
  • BMXMF — bioMérieux S.A.
  • CHEOF — Cochlear Limited
  • CHEOY — Cochlear Limited
  • CHJTF — CSPC Pharmaceutical Group Limited
  • CSPCY — CSPC Pharmaceutical Group Limited
  • FSPKF — Fisher & Paykel Healthcare Corporation Limited

More Medical - Diagnostics & Research companies

  • SPDE — Speedus Corp.
  • SZLSF — StageZero Life Sciences Ltd.
  • TDSGF — Telo Genomics Corp.
  • TELO.V — Telo Genomics Corp.
  • THOXF — BioPorto A/S
  • TMO — Thermo Fisher Scientific Inc.
  • TMO.NE — Thermo Fisher Scientific Inc.
  • TOMDF — Todos Medical Ltd.
  • TTOO — T2 Biosystems, Inc.
  • TWST — Twist Bioscience Corporation
  • VCYT — Veracyte, Inc.
  • VIMGF — Vimian Group AB (publ)

News

Latest Market News